Welcome to the international HTA database

Showing [23369 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Theralite for treatment of renal failure in patients with multiple myeloma
2014	NIHR Health Technology Assessment programme	Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year olds
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Clinical review report. Lurasidone (Latuda - Sunovion Pharmaceuticals Inc.) indication: schizophrenia
2014	NIHR Health Technology Assessment programme	Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Kangaroo™ feeding tube with IRIS technology for aid in nasogastric tube placement
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Idelalisib (Zydelig(R)) in addition to rituximab for the treatment of relapsed chronic lymphocytic leukaemia
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Azelastine - HCl and fluticasone propionate
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Drug-eluting stents with CD34 antibodies for the treatment of coronary artery disease
2014	NIHR Health Technology Assessment programme	Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pharmacoeconomic review report. Lurasidone (Latuda - Sunovion Pharmaceuticals Inc.) indication: schizophrenia
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Urine testing in long-term care: guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Online programs for weight loss
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lyophilized plasma for the treatment of adults with hemorrhagic shock: clinical and cost-effectiveness, safety, and guidelines
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Aflibercept solution (Eylea) for visual impairment due to macular oedema secondary to branch retinal vein occlusion
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Vasoprotectives: efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoids
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Retinal surgeries in non-hospital facilities: clinical and cost-effectiveness
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Sutureless aortic valve replacement in patients with severe aortic valve stenosis
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Pertuzumab (Perjeta) for HER2-positive locally advanced, inflammatory or early breast cancer – neo-adjuvant in combination with trastuzumab and docetaxel
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suboxone versus methadone for the detoxification of patients addicted to prescription opioids: a review of comparative clinical effectiveness, safety, and guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Addendum to the notice on the efficacy of rehabilitative interventions and pharmacological therapies for children aged 2 to 12 Years with autism spectrum disorder (ASD)]
2014	University of York	Dementia carers. Effective information, support and services to meet their needs
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Balloon sinuplasty for chronic rhinosinusitus
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Pacritinib for myelofibrosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Viscosupplementation for the treatment of osteoarthritis of the knee: clinical effectiveness and guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Change in the Proton Pump Inhibitors (PPI) terms for coverage: a follow-up]
2014	University of York	Preventing falls in hospitals
2014	NIHR Horizon Scanning Centre (NIHR HSC)	SoftVue™ system for diagnostic breast imaging
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[High-dose rate brachytherapy in the treatment of mobile tongue cancer]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Immediate initiation of continuous positive airway pressure compared with delayed initiation: clinical effectiveness and guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Implantable carotid sinus baroreflex device for treatment of drug resistant hypertension
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Paclitaxel poliglumex (Xyotax) for advanced ovarian cancer – maintenance therapy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	iTClamp for controlling compressible gemorrhage in adults: clinical effectiveness, cost-effectiveness, and safety
2014	University of York	Impact of early warning systems on patient outcomes
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Sialendoscopy for the management of obstructive salivary gland disease]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Triple therapy for hepatitis C in previous non-responders: a review of the clinical effectiveness and safety
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Basic fibroblast growth factor (b-FGF) for the treatment of tympanic membrane perforation
2014	Medical Advisory Secretariat (MAS)	Multiple intravenous infusions. Part II
2014	NIHR Health Technology Assessment programme	The effectiveness of sexual health interventions for people with severe mental illness: a systematic review
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Necitumumab in combination with gemcitabine and cisplatin for advanced and metastatic non-small cell lung cancer – first line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nutritional supplementation for patients with cancer: a review of the clinical effectiveness and guidelines
2014	University of York	Preventing falls in the community
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sofosbuvir for the treatment of patients with genotype 4 hepatitis C: a review of the clinical efficacy, cost-effectiveness, and guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	New and emerging orthopaedic technologies in the Australian and New Zealand public health services
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Midostaurin for newly diagnosed FLT3-mutated acute myeloid leukaemia – first line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interventions for non-elderly patients who are high users of ambulatory and emergency medical services: clinical and cost-effectiveness
2014	University of York	Preventing pressure ulcers
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Outpatient self-dialysis programs for patients with chronic renal conditions: clinical and cost-effectiveness, safety, and guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Miethke proSA adjustable gravitational shunt for hydrocephalus
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Custirsen for locally advanced or metastatic hormone-relapsed prostate cancer – first and second line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-invasive prenatal testing: a review of the cost effectiveness and guidelines
2014	Institute for Clinical Evaluative Sciences (ICES)	Health outcomes for better information and care (HOBIC): acute care and home care in Ontario 2013
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Profile of individuals insured by the public prescription drug insurance plan who have received treatment for hepatitis C (HCV)]
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Collagenase Clostridium histolyticum (Xiapex) for Peyronie's disease – first line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Foley catheter removal following hip surgery in elderly patients: benefits, harms, and guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	HPV OncoTect E6, E7 mRNA assay to guide colposcopy referral in cervical cancer screening
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Lumacaftor and ivacaftor combination therapy for cystic fibrosis – first line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Trientine for treatment of Wilson's disease: clinical and cost-effectiveness, and safety
2014	Institute for Clinical Evaluative Sciences (ICES)	Ontario stroke evaluation report 2014: Ontario stroke report cards
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of intravenous immunoglobulins - a review of management strategy experiences and the available evidence]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	SYMBIS for neurosurgery and spine application: clinical and cost-effectiveness
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SentiMag and Sienna+ for sentinel lymph node localisation in breast cancer
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Velcalcetide for secondary hyperparathyroidism – first line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Magnetic resonance spectroscopic imaging for prostate disease detection: clinical and cost-effectiveness, and guidelines
2014	Institute for Clinical Evaluative Sciences (ICES)	900,000 days in hospital: The annual impact of smoking, alcohol, diet and physical activity on hospital use in Ontario
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Stereotactic Body Radiation Therapy (SBRT)]
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Spheroids of human autologous matrix-associated chondrocytes (Chondrosphere) for articular cartilage defects
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ombitasvir/paritaprevir/ritonavir and dasabuvir
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Neonatal screening for lysosomal storage disorders
2014	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Effectiveness and efficacy of minimally invasive lung volume reduction surgery for emphysema]
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Autologous Muscle Derived Cells-Urethral Sphincter Repair (AMDC-USR) for stress urinary incontinence
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Next generation DNA sequencing: a review of the cost effectiveness and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Technology assessment of molecular pathology testing for the estimation of prognosis for common cancers
2014	Health Quality Ontario (HQO)	Turning for the prevention and management of pressure ulcers: OHTAC Recommendation
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Alpha-1 antitrypsin (Respreeza) for emphysema associated with alpha-1 antitrypsin deficiency – maintenance therapy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vitamin D testing in the general population: clinical and cost-effectiveness and guidelines
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Purified botulinum toxin type A (Botox) for post-stroke lower limb spasticity
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Icatibant for patients with type III hereditary angioedema: a review of clinical effectiveness and harms
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force
2014	Health Quality Ontario (HQO)	Preventing pressure ulcers: a multisite randomized controlled trial in nursing homes
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Adalimumab (Humira) for severe chronic plaque psoriasis in children and adolescents – second line
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for vitamin D deficiency: systematic review for the U.S. Preventive Services Task Force Recommendation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014	NIHR Health Technology Assessment programme	The use of fenestrated and branched endovascular aneurysm repair (fEVAR & bEVAR) for juxta-renal and thoraco-abdominal aneurysms: a systematic review and cost effectiveness analysis
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Tocilizumab (RoACTEMRA) for giant cell arteritis – first and second line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Single-use medical devices reprocessed by third party/licenced reprocessors: patient benefits and harms, cost-effectiveness, and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Behavioral counseling to promote a healthy lifestyle for cardiovascular disease prevention in persons with cardiovascular risk factors: an evidence update for the U.S. Preventive Services Task Force
2014	Health Quality Ontario (HQO)	Turning for ulcer reduction (TURN) study: an economic analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Routine ordering of primary pathology examinations in Canada
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for high blood pressure in adults: a systematic evidence review for the U.S. Preventive Services Task Force
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transmission of infectious agents and risk of injury from patient transfer boards in healthcare settings: clinical evidence
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Ramucirumab in combination with paclitaxel for advanced gastric cancer and gastro-oesophageal junction adenocarcinoma after prior chemotherapy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug interventions for chronic non-cancer pain: guidelines and recommendations
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[Valuation of EQ-5D-5L health states in Korea]
2014	Health Quality Ontario (HQO)	Pre-emptive oral non-steroidal anti-inflammatory drugs or acetaminophen for knee arthroscopy: a rapid review
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Couples therapy for adults experiencing relationship distress: a review of the clinical evidence and guidelines
2014	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Implantable cardiac resyncronization therapy and defibrillator (CRT-D) in patient with heart failure
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	NxStage home hemodialysis use in remote or rural settings with well water: clinical effectiveness, cost-effectiveness, and guidelines
2014	NIHR Health Technology Assessment programme	Clinical effectiveness of interventions for treatment-resistant anxiety in older people; a systematic review
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Onartuzumab for metastatic Met positive gastric or gastro-oesophageal junction cancer
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Non-drug interventions for chronic non-cancer pain: guidelines and recommendations